DeepMed Research

ICAHN School of Medicine At Mount Sinai

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1963-01-01

Employees: 5K

Market Cap: -

Website: http://www.mssm.edu

Clinical Trials

Impact of Prophylactic Ephedrine on Fetal Heart Tracing and Uterine Tetanic Contraction After CSE

Phase 4

Recruiting

Conditions: Labor

Interventions: Drug: Normal Saline Placebo
Drug: Ephedrine

First Posted Date: 2023-05-24

Last Posted Date: 2025-05-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 135

Registration Number: NCT05873218

Locations: 🇺🇸
Icahn School of Medicine at Mount SInai, New york, New York, United States

Dupilumab in the Treatment of Pediatric Alopecia Areata

Phase 2

Recruiting

Conditions: Alopecia Areata

Interventions: Drug: Placebo
Drug: Dupilumab

First Posted Date: 2023-05-19

Last Posted Date: 2025-02-07

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 76

Registration Number: NCT05866562

Locations: 🇺🇸
University of California, Irvine, Irvine, California, United States
🇺🇸
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, United States
🇺🇸
Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States

and more 1 locations

Methodology Issues in a Tailored Light Treatment for Persons With Dementia - Aim 2

Not Applicable

Completed

Conditions: Alzheimer's Disease
Sleep Disturbance

Interventions: Device: Active Lighting Intervention
Device: Control Lighting Intervention

First Posted Date: 2023-05-01

Last Posted Date: 2025-04-15

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 135

Registration Number: NCT05837819

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Reparixin in Patients with Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)

Phase 2

Recruiting

Conditions: Myelofibrosis (PMF)
Post Essential Thrombocythemia Myelofibrosis (ET-MF)
Post Polycythemia Vera Related Myelofibrosis (PV-MF)

Interventions: Drug: reparixin

First Posted Date: 2023-04-28

Last Posted Date: 2024-12-02

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 26

Registration Number: NCT05835466

Locations: 🇺🇸
Roswell Park Cancer Institute, Buffalo, New York, United States
🇺🇸
Wake Forest Baptist Health Comprehensive Cancer Center, Winston-Salem, North Carolina, United States
🇺🇸
Ruttenberg Treatment Center, New York, New York, United States

Rectus Sheath Block in Cardiac Surgery

Not Applicable

Recruiting

Conditions: Cardiac Disease
Postoperative Pain

Interventions: Procedure: Rectus sheath block

First Posted Date: 2023-04-27

Last Posted Date: 2024-08-09

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 200

Registration Number: NCT05833048

Locations: 🇺🇸
Mount Sinai Morningside Hospital Center, New York, New York, United States

Cardiovascular Precision Medicine & Remote Intervention

Not Applicable

Completed

Conditions: Hypertension

Interventions: Behavioral: Remote Intervention

First Posted Date: 2023-04-18

Last Posted Date: 2024-10-29

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 25

Registration Number: NCT05814562

Locations: 🇺🇸
Elmhurst Hospital Center, New York, New York, United States

Thulium vs. Hol:YAG Laser

Not Applicable

Completed

Conditions: Nephrolithiasis

Interventions: Device: Thulium Fibre Laser

First Posted Date: 2023-04-11

Last Posted Date: 2025-01-29

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 82

Registration Number: NCT05808257

Locations: 🇺🇸
Mount Sinai West, New York, New York, United States

Ruxolitinib in Seborrheic Dermatitis

Phase 2

Completed

Conditions: Seborrheic Dermatitis

Interventions: Drug: Ruxolitinib 1.5% Cream

First Posted Date: 2023-03-28

Last Posted Date: 2025-05-06

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 45

Registration Number: NCT05787860

Locations: 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States

Mitigation of Postoperative Delirium in High-Risk Patients

Not Applicable

Recruiting

Conditions: Post-operative Delirium
Decision Support Systems, Clinical
Cognitive Impairment

Interventions: Other: Clinical Decision Support

First Posted Date: 2023-03-21

Last Posted Date: 2023-10-03

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 24426

Registration Number: NCT05777187

Locations: 🇺🇸
Mount Sinai Health System, New York, New York, United States

The Effect of a Lighting Intervention on Sleep in Parkinson Disease

Not Applicable

Active, not recruiting

Conditions: Parkinson Disease
Sleep Disturbance

Interventions: Device: Tailored Lighting Intervention (TLI)
Device: Actigraph

First Posted Date: 2023-03-16

Last Posted Date: 2025-02-28

Lead Sponsor: Icahn School of Medicine at Mount Sinai

Target Recruit Count: 48

Registration Number: NCT05771558

Locations: 🇺🇸
Mount Sinai Beth Israel, New York, New York, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy